Search PDMR transactions

Notifier
Name of person with notification obligation
Anette Lindqvist
Reason for notification
Closely associated
No
Person discharging managerial responsibilities
Anette Lindqvist
Position
Chief Financial Officer (CFO)
Initial notification
Yes
Amendment
No
Details of amendment
Details of the Issuer/emission allowance market participant/auction platform/auctioneer/auction monitor
Name of issuer
Xbrane Biopharma AB
Issuer´s LEI code
5493008DKD05APTKQO39
Details of transaction
Type of financial instrument Financial instrument ISIN code Nature of transaction Linked to the exercise of a share option programme Volume Unit Price per unit Currency code Transaction date Place of the transaction
Subcription warrant Xbrane Biopharma AB SE0007789409 Allotment 3,000 Quantity 0.00 SEK 05/09/2023 Outside a trading venue
Subcription warrant Xbrane Biopharma AB SE0007789409 Exercise decrease 3,000 Quantity 0.00 SEK 05/09/2023 Outside a trading venue
Share Xbrane Biopharma AB SE0007789409 Exercise increase 3,000 Quantity 0.2242 SEK 05/09/2023 Outside a trading venue
Aggregation
Financial instrument ISIN code Nature of transaction Transaction date Place of the transaction Volume Weighted average price
Xbrane Biopharma AB SE0007789409 Allotment 05/09/2023 Outside a trading venue 3,000 (Quantity) 0.00 SEK
Xbrane Biopharma AB SE0007789409 Exercise decrease 05/09/2023 Outside a trading venue 3,000 (Quantity) 0.00 SEK
Xbrane Biopharma AB SE0007789409 Exercise increase 05/09/2023 Outside a trading venue 3,000 (Quantity) 0.2242 SEK
<< Back